Immune Oncology Research Institute

A non-profit research institution aimed to advance research that can help prevent, treat, and cure cancer and make them available for beneficiaries.

[Immune Oncology Research Institute @ImmoncInstitute]

🧩 SKYSCRAPER-06 found no PFS or OS benefit with tiragolumab + atezolizumab + chemotherapy vs pembrolizumab + chemotherapy in NSCLC.

🧭 Promising biology did not translate into benefit.

Read: https://t.co/gITxC1fhvk

#NSCLC #Immunotherapy #immuneoncologyresearchinstitute

[Immune Oncology Research Institute @ImmoncInstitute]

🚀Can next-generation immunotherapy help overcome resistance in difficult-to-treat cancers?

Botensilimab + balstilimab is showing encouraging early results in MSS colorectal cancer and ovarian cancer. 🧬

📖 Read the full article: https://t.co/gk7RvmM9JK

#IMMONC #ImmunoOncology

[Immune Oncology Research Institute @ImmoncInstitute]

🏆 We are proud to announce that our Scientific Director, Dr. Samvel Bardakhchyan, has received the Mentorship Yvonne Award 2026 at the OncoDaily Party in Chicago!
#YvonneAwards2026 #MentorshipAward #OncoDaily #Oncology #CancerCare #Mentorship #Healthcare #Research #IMMONC

[Immune Oncology Research Institute @ImmoncInstitute]

🎉 We are delighted to share, that Dr. Elen Baloyan, Clinical Research Physician at IMMONC, has been selected as the first Cancer Groundshot Virtual Fellow through the BG Lab–OncoDaily partnership.
#IMMONC #CancerGroundshot #Oncology #CancerResearch #ClinicalResearch #OncoDaily

[Immune Oncology Research Institute @ImmoncInstitute]

The U.S. FDA has approved Decnupaz (pivekimab sunirine-pvzy) for adults with BPDCN, a rare and aggressive blood cancer with few treatment options.

Read more: https://t.co/WbdRQ54CCs

#BPDCN #immuneoncologyresearchinstitute #hematology

[Immune Oncology Research Institute @ImmoncInstitute]

Proud to share that our CEO, Gevorg Tamamyan , received the 🏆 SLACOM 2026 Award for Global Oncology Leadership for his contributions to pediatric oncology and global cancer collaboration.

Congratulations on this remarkable achievement 👏
#SLACOM #ASCO #IMMONC

[Immune Oncology Research Institute @ImmoncInstitute]

🎓 We are proud to share that Dr.Ruzanna Papyan, lead of our Pediatric Oncology Team, defended her PhD thesis on survival factors in children and adolescents with musculoskeletal sarcomas in Armenia, under the supervision of @GevTamamyan.

Read more: https://t.co/E61byIbDpF

[Immune Oncology Research Institute @ImmoncInstitute]

We are looking for a motivated professional to join our team.
Position: Diagnostic Access Coordinator
Location: 7 Nersisyan Str, Yerevan, Armenia (Yeolyan Hematology and Oncology Center)
Employment Type: Full-Time, On-site
Follow the link for more details: https://t.co/t62m7KJqNt

[Immune Oncology Research Institute @ImmoncInstitute]

Dr. Aharon Tsaturyan, MD, presented the BPDCN International Registry at Vickino. The registry gathers global real-world data to better understand this rare malignancy and guide evidence-based treatment.

Learn more:
https://t.co/Fu3MDEHegy
#ImmOnc #BPDCN

[Immune Oncology Research Institute @ImmoncInstitute]

The CEO of IMMONC @GevTamamyan Featured on Global Health Dialogues with HRH Princess Dina Mired

[Princess Dina Mired @dinamired]

🎙️ New Episode Release
📽️ Watch today https://t.co/URQc8B2kK8

Global Health Dialogues with Princess Dina and Dr. Gevorg Tamamyan @GevTamamyan, Editor-in-chief of OncoDaily @oncodaily, Chairman & Professor, Department of Hematology & Pediatric Oncology, YSMU,

CEO of Immune Oncology Research Institute,
President of International Society of Pediatric Oncology (SIOP) Asia Continental Branch,
President of Pediatric Oncology East and Mediterranean (POEM) Group,
Co-Chair of St. Jude Global EURO Regional Advisory Committee.

How can one doctor’s vision and leadership transform a country’s pediatric cancer care, empower young health professionals, and ensure every child has access to life-saving treatment?

Princess Dina Mired sits down with Dr. Gevorg Tamamyan to explore his remarkable journey from a young clinician in Armenia to a global leader in pediatric oncology, and to discuss how vision, mentorship, and bold action can transform cancer care systems, advance equity, and save children’s lives across regions and borders.

Their conversation covers:

🔹Dr. Gevorg Tamamyan’s journey from Armenia to global leadership in pediatric oncology
🔹Building high-quality childhood cancer care in a low- and middle-income country
🔹Leadership, resilience, and turning vision into action
🔹The role of mentorship and empowering young health professionals
🔹Achieving equity in cancer care and refusing geographic disadvantage
🔹Establishing advanced services, including bone marrow transplantation
🔹Training teams and building sustainable health systems
🔹The importance of research, data, and global collaboration
🔹Ensuring access to care through the City of Smile Foundation
🔹Connecting regions and countries through international oncology networks
🔹Rethinking cancer communication and founding OncoDaily
🔹Balancing global leadership with family life
🔹The future of global health: transparency, accountability, and delivery.

#GlobalHealthDialogues #PrincessDinaMired #PodcastEpisode #GlobalHealth #ChildhoodCancer #PediatricOncology #CancerCare #Oncology #CancerEquity #CancerJustice
---
@KHCFKHCC
@UICC
@CCan_org
@NCDalliance
@WorldSIOP
@WHO

[Immune Oncology Research Institute @ImmoncInstitute]

IMMONC Research Physician @ruzanna_papyan presenting the Role of Telemedicine in Pediatric Sarcomas in Armenia at the 4th Armenian Oncology Congress

[Shushan Hovsepyan @shhovsepyan]

✨Dr. @ruzanna_papyan’s talk on the role of #telemedicine in #pediatric #sarcomas in #Armenia

@ImmoncInstitute @YeolyanCenter

[Immune Oncology Research Institute @ImmoncInstitute]

The CEO of IMMONC @GevTamamyan, with a very mysterious presentation for the 4th Armenian Oncology Congress

[Shushan Hovsepyan @shhovsepyan]

Disclosing the secret))
#gg #going_global
@GevTamamyan as always continuously provides motivation and inspiration.
#Rolemodel

@oncodaily
@YeolyanCenter
@ImmoncInstitute

[Immune Oncology Research Institute @ImmoncInstitute]

Julia Hoveyan (@JHoveyan), the PI of the Rare Embryonal Tumors' Registry, presenting on o overview on the registry at the 4th Armenian Oncology Congress

[Shushan Hovsepyan @shhovsepyan]

International Registry of Rare #Embryonal Tumors of #CNS presented by @JHoveyan
Have you ever encountered a case of rare #CNS embryonal tumors?
✔️If yes, join our international #registry

https://t.co/jMAHNVS7Ny
@ImmoncInstitute @YeolyanCenter
#cns #pedonc #oncology #global

[Immune Oncology Research Institute @ImmoncInstitute]

Tatev Margaryan, the Project Manager of IMMONC, presenting the @cancerandcrisis at the 4th Armenian Oncology Congress

[Shushan Hovsepyan @shhovsepyan]

✨The impressive work of @cancerandcrisis by Tatev Margaryan

@ImmoncInstitute
@oncodaily
Jemma Arakelyan
@GevTamamyan @SullivanProf @WendyYared @AlisaKamalyan

[OncoDaily @oncodaily]

🔊 Meet the speakers of the First Global OncoThon

🧑🏻‍⚕️ Prof. Scott Howard

📍 Position: Former General Secretary of the International Society of Paediatric Oncology - SIOP, Deputy Director of the Yeolyan Hematology and Oncology Center, Ministry of Health of Armenia, Chief Development Officer of the Barcelona Children's Hospital Sant Joan de Déu, CEO of Resonance, Senior Adviser to the Immune Oncology Research Institute

🗓️ Mark your calendar for February 15th, 2024

✨Join us on the International Childhood Cancer Day!

https://t.co/WykIOxpHEg

#oncothon24 #oncothon2024 #pediatriccancer #iccd2024 #cancer #oncology #oncoheroes #oncodaily

[Immune Oncology Research Institute @ImmoncInstitute]

#ourteam
Meet our Project Manager Tatevik Margaryan!

🎗️Tatevik Margaryan, MSc, is a psychologist and a public health specialist.
#ourteam #immonc #research #oncology

[Immune Oncology Research Institute @ImmoncInstitute]

Meet our #fellows 🧐
Introducing our new fellow, Lusine Harutyunyan, MD, a hematologist-oncologist at the Yeolyan Hematology and Oncology Center.
#ourteam #immonc #fellowship #research #oncology #immunooncology

[Nerses Ghahramanyan @NersesGH]

BPDCN International Registry is a collaboration of hospitals, specialists, and patients on BPDCN, and it is growing rapidly, involving people from various continents. #ASHAnnualMeeting #BPDCNRegistry, @oncodaily @ImmoncInstitute @doctorpemm @Ramikomrokji
https://t.co/ZgruujXRjo

[Immune Oncology Research Institute @ImmoncInstitute]

We extend our heartfelt wishes for a happy and prosperous New Year to all.

https://t.co/Iqt0baKp0m

[Immune Oncology Research Institute @ImmoncInstitute]

As we come to the end of 2023, we reflect upon the achievements of the Immune Oncology Research Institute (#IMMONC) throughout the year. 🎄🎉
🧵👇

[Immune Oncology Research Institute @ImmoncInstitute]

As we express our gratitude to #ourteam, board of trustees, advisors, fellows, collaborators, sponsors and partners and every individual who engaged with IMMONC this year, we remain confident in our mission to advance #cancercare through #research and #innovation.